ALFACELL CORP
SC 13G/A, 1998-07-23
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: FIDELITY MT VERNON STREET TRUST, N-30D, 1998-07-23
Next: PHARMOS CORP, S-3/A, 1998-07-23




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                    -----------------------------------------

                                AMENDMENT NO. 1

                                       TO

                                  SCHEDULE 13G

                    Under the Securities Exchange Act of 1934
                    -----------------------------------------


                              ALFACELL CORPORATION
                    -----------------------------------------
                                (Name of Issuer)


                    Common Stock, par value $0.001 per share
                   ------------------------------------------
                         (Title of Class of Securities)

                                    015404106
                                  -------------
                                 (CUSIP Number)

                                  July 10, 1998
                                -----------------
             (Date of Event Which Requires Filing of the Statement)

         Check the  appropriate box to designate the rule pursuant to which this
Schedule is filed:

                                            [_]   Rule 13d-1(b)
                                            [X]   Rule 13d-1(c)
                                            [_]   Rule 13d-1(d)

         *The  remainder  of this cover page shall be filled out for a reporting
person's  initial  filing on this  form with  respect  to the  subject  class of
securities,  and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.

         The information  required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise  subject to the  liabilities of that section of
the Act but shall be subject to all other  provisions of the Act  (however,  see
the Notes to Schedule 13G).

                                        1

<PAGE>

CUSIP NO. 015404106                    13G                    Page 2 of 7 pages

     1     NAMES OF REPORTING PERSONS
           S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
           Paramount Capital Asset Management, Inc.

     2     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 
                                                              (a)[_] (b)[_]

     3     SEC USE ONLY


     4     CITIZENSHIP OR PLACE OF ORGANIZATION
           Delaware

                 NUMBER OF                     5      SOLE VOTING POWER       
                  SHARES                              None                    
               BENEFICIALLY                    6      SHARED VOTING POWER     
                 OWNED BY                             2,019,800               
                   EACH                        7      SOLE DISPOSITIVE POWER  
                 REPORTING                            None                    
                  PERSON                       8      SHARED DISPOSITIVE POWER
                   WITH                               2,019,800               
                                                                              
                          
     9     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
           2,019,800

    10     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES*
                                                                           [_] 
    11     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
           11.1%

    12     TYPE OF REPORTING PERSON*
           CO


<PAGE>

CUSIP NO. 015404106                    13G                    Page 3 of 7 pages

     1    NAMES OF REPORTING PERSONS S.S. OR I.R.S.  IDENTIFICATION NO. OF ABOVE
          PERSON

          Aries Domestic Fund, L.P.
    
     2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

                                                               (a)[_]   (b)[_]
     3    SEC USE ONLY

     4    CITIZENSHIP OR PLACE OF ORGANIZATION
          Delaware

           NUMBER OF           5      SOLE VOTING POWER       
           SHARES                      None                   
        BENEFICIALLY           6      SHARED VOTING POWER     
          OWNED BY                     651,100                
            EACH               7      SOLE DISPOSITIVE POWER   
          REPORTING                    None                    
           PERSON              8      SHARED DISPOSITIVE POWER 
            WITH                       651,100                 

     9     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
           651,100

    10     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES*
                                                                        [_]
    11     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
           3.7%

    12     TYPE OF REPORTING PERSON*
           PN


<PAGE>

CUSIP NO. 015404106                    13G                    Page 4 of 7 pages


    1     NAMES OF REPORTING PERSONS
          S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

          The Aries Trust

    2     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
                                                                  (a)[_]
                                                                  (b)[_]
    3     SEC USE ONLY

    4     CITIZENSHIP OR PLACE OF ORGANIZATION
          Cayman Islands

                   NUMBER OF                    5     SOLE VOTING POWER
                    SHARES                             None
                 BENEFICIALLY                   6     SHARED VOTING POWER
                   OWNED BY                            1,368,700
                     EACH                       7     SOLE DISPOSITIVE POWER
                   REPORTING                           None
                    PERSON                      8     SHARED DISPOSITIVE POWER 
                     WITH                              1,368,700

    9     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
          1,368,700

   10     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES*
                                                                       [_]
   11     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
          7.7%

   12     TYPE OF REPORTING PERSON* OO (see Item 2)


<PAGE>


CUSIP NO. 015404106                    13G                    Page 5 of 7 pages

     1    NAMES OF REPORTING PERSONS S.S. OR I.R.S.  IDENTIFICATION NO. OF ABOVE
          PERSON

          Lindsay A. Rosenwald, M.D.

     2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
                                                                    (a)[_]
                                                                    (b)[_]
     3    SEC USE ONLY


     4   CITIZENSHIP OR PLACE OF ORGANIZATION
          United States

                 NUMBER OF                     5      SOLE VOTING POWER
                  SHARES                               None
               BENEFICIALLY                    6      SHARED VOTING POWER      
                 OWNED BY                              2,019,800              
                   EACH                        7      SOLE DISPOSITIVE POWER  
                 REPORTING                             None                   
                  PERSON                       8      SHARED DISPOSITIVE POWER
                   WITH                                2,019,800              
                                                                              

     9    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
          2,019,800

    10    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES*
                                                                          [_]
    11    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
          11.1%

    12    TYPE OF REPORTING PERSON*
          IN


<PAGE>

         This  Amendment  No. 1 (the  "Amendment")  amends and  supplements  the
following Items of the Reporting  Persons' Statement on Schedule 13G, dated July
10, 1998 (the "Schedule").

Item 4.        Ownership:

         The  information  contained in Item 4 to the Schedule is hereby amended
and restated to read in its entirety as follows:

               For  information  concerning  the ownership of Common
               Stock of the Company by the  Reporting  Persons,  see
               Items 5 through 9 of the cover  pages to this
               schedule 13G and footnotes thereto.


                                        6

<PAGE>

                                   SIGNATURES

         After reasonable inquiry and to the best of my knowledge and
belief,  I certify  that the  information  set forth in this  statement is true,
complete and correct.


                                 PARAMOUNT CAPITAL ASSET MANAGEMENT, INC.

Dated:   July 23, 1998
          New York, NY              By /s/ Lindsay A. Rosenwald, M.D.
                                      -------------------------------
                                       Lindsay A. Rosenwald, M.D.
                                       President


                                 ARIES DOMESTIC FUND, L.P.
                                    By  Paramount Capital Asset Management, Inc.
                                         General Partner

Dated:   July 23, 1998
          New York, NY               By /s/ Lindsay A. Rosenwald, M.D.
                                       -------------------------------
                                        Lindsay A. Rosenwald, M.D.
                                        President


                                 THE ARIES TRUST
                                 By Paramount Capital Asset Management, Inc.
                                 Investment Manager

Dated:   July 23, 1998
          New York, NY             By /s/ Lindsay A. Rosenwald, M.D.
                                      -------------------------------
                                       Lindsay A. Rosenwald, M.D.
                                       President


Dated:   July 23, 1998
         New York, NY              By  /s/ Lindsay A. Rosenwald, M.D.
                                       ------------------------------
                                       Lindsay A. Rosenwald, M.D.


                                        7



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission